Segment Information

6 Months Ended

Dec. 31, 2019

Note 13. Segment Information

The Company has one operating and reporting segment (oncology systems group), which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients. The Company’s Chief Executive Officer, its Chief Operating Decision Maker, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company does not assess the performance of its individual product lines on measures of profit or loss, or asset-based metrics. Therefore, the information below is presented only for revenues and long-lived tangible assets by geographic area.

Disaggregation of Revenues

The Company disaggregates its revenues from contracts by geographic region, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. Additionally, the Company typically recognizes revenue at a point in time for product revenue and recognizes revenue over time for service revenue.

Revenues attributed to a country or region is based on the shipping addresses of the Company’s customers. The following summarizes revenue by geographic region (in thousands):

	Three Months Ended December 31,				Six Months Ended December 31,
	2019		2018		2019		2018
Americas	$	32,393	$	28,249	$	61,822	$	60,943
Europe, Middle East, India and Africa		33,999		41,941		65,599		77,976
Asia Pacific		14,815		18,675		28,882		30,852
Japan		17,619		13,453		32,100		28,376
Total	$	98,826	$	102,318	$	188,403	$	198,147

Information regarding geographic areas in which the Company has long-lived tangible assets is as follows (in thousands):

	December 31,		June 30,
	2019		2019
Americas	$	13,996	$	13,853
Europe, Middle East, India and Africa	$	429		575
Asia Pacific		1,232		1,419
Japan		1,320		1,275
Total	$	16,977	$	17,122